{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:29:30Z","timestamp":1786382970524,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Two vaccines are currently licensed against\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    malaria but offer only partial protection that wanes, necessitating repeated dosing that is challenging to implement where it is needed most. We previously identified a subset of Kenyan adults with naturally acquired clinical immunity using controlled human malaria infection studies (CHMI,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200986\/142; ClinicalTrials.gov - NCT02739763). Subsequent studies showed that clinical immunity was strongly correlated with IgG Fc-mediated functional activity against whole merozoites. Here, to zoom in on specific targets associated with clinical immunity, we use samples from the CHMI study and a custom protein microarray (KILchip) to measure IgG antibody reactivity against seventy recombinant merozoite antigens. We identify the top-ranking antigens by analyzing the data using five distinct statistical methodologies: the nonparametric Wilcoxon rank sum test, a Cox proportional hazards model, a modified Poisson regression model, and the machine learning Least Absolute Shrinkage and Selection Operator (LASSO) and random forest models. Antibodies against MSP1, MSP11, RAMA, MSP7, PF3D7_1401600 (PHISTB) and PTEX150 were consistently associated with clinical immunity and in combination predicted complete protection. These findings may be useful to prioritize the next generation of malaria blood stage vaccine candidates.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-72716-x","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:46:30Z","timestamp":1777988790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-7956","authenticated-orcid":false,"given":"Rodney","family":"Ogwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene N.","family":"Nkumama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Mwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Odera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nyamako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"F\u00fcrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinter","family":"Kimathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Njuguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-8905","authenticated-orcid":false,"given":"B. Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-1414","authenticated-orcid":false,"given":"Mainga","family":"Hamaluba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CHMI-SIKA Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaydah","family":"de Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domitila","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija Said","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Mosobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdirahman I.","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donwilliams","family":"Omuoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Shangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Wambua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Musembi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Musyoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Muthui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedidah","family":"Mwacharo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ndungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Ngoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnstone","family":"Makale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Ogwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ngoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis O.","family":"Odera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith H. A.","family":"Osier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ong\u2019echa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kinyanjui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Kivisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhards","family":"Ogutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Olewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-7128","authenticated-orcid":false,"given":"Melissa C.","family":"Kapulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7549","authenticated-orcid":false,"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tuju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-5375","authenticated-orcid":false,"given":"Faith H. A.","family":"Osier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"72716_CR1","unstructured":"WHO, World malaria report 2023. (World Health Organization, Geneva, 2023)."},{"key":"72716_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature24059","volume":"550","author":"RW Snow","year":"2017","unstructured":"Snow, R. W. et al. The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900. Nature 550, 515\u2013518 (2017).","journal-title":"Nature"},{"key":"72716_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(24)00194-6","volume":"403","author":"P Adepoju","year":"2024","unstructured":"Adepoju, P. Routine malaria vaccinations begin. Lancet. 403, 423 (2024).","journal-title":"Lancet"},{"key":"72716_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","volume":"403","author":"MS Datoo","year":"2024","unstructured":"Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet. 403, 533\u2013544 (2024).","journal-title":"Lancet"},{"key":"72716_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","volume":"24","author":"A Dicko","year":"2024","unstructured":"Dicko, A. et al. Seasonal vaccination with RTS,S\/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial. Lancet. Infect. Dis. 24, 75\u201386 (2024).","journal-title":"Lancet. Infect. Dis."},{"key":"72716_CR6","unstructured":"W. H. Organization, Malaria vaccines: preferred product characteristics and clinical development considerations. (World Health Organization, 2022)."},{"key":"72716_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","volume":"28","author":"K Marsh","year":"2006","unstructured":"Marsh, K. & Kinyanjui, S. Immune effector mechanisms in malaria. Parasite Immunol. 28, 51\u201360 (2006).","journal-title":"Parasite Immunol."},{"key":"72716_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0169-4758(96)10015-6","volume":"12","author":"JF Trape","year":"1996","unstructured":"Trape, J. F. & Rogier, C. Combating malaria morbidity and mortality by reducing transmission. Parasitol. Today 12, 236\u2013240 (1996).","journal-title":"Parasitol. Today"},{"key":"72716_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen, S., Mc, G. I. & Carrington, S. Gamma-globulin and acquired immunity to human malaria. Nature 192, 733\u2013737 (1961).","journal-title":"Nature"},{"key":"72716_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(62)90725-0","volume":"280","author":"JC Edozien","year":"1962","unstructured":"Edozien, J. C., Gilles, H. M. & Udeozo, I. O. K. ADULT AND CORD-BLOOD GAMMA-GLOBULIN AND IMMUNITY TO MALARIA IN NIGERIANS. Lancet. 280, 951\u2013955 (1962).","journal-title":"Lancet"},{"key":"72716_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4269\/ajtmh.1964.13.237","volume":"13","author":"IA McGregor","year":"1964","unstructured":"McGregor, I. A. The Passive Transfer of Human Malarial Immunity. Am. J. Tropical Med. Hyg. 13, 237\u2013239 (1964).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"72716_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","volume":"45","author":"A Sabchareon","year":"1991","unstructured":"Sabchareon, A. et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45, 297\u2013308 (1991).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"72716_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12688\/wellcomeopenres.14909.1","volume":"3","author":"MC Kapulu","year":"2018","unstructured":"Kapulu, M. C., Njuguna, P. & Hamaluba, M. M. Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity. Wellcome Open Res. 3, 155 (2018).","journal-title":"Wellcome Open Res"},{"key":"72716_CR14","doi-asserted-by":"publisher","first-page":"e146443","DOI":"10.1172\/jci.insight.146443","volume":"6","author":"MC Kapulu","year":"2021","unstructured":"Kapulu, M. C. et al. Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection. JCI Insight 6, e146443 (2021).","journal-title":"JCI Insight"},{"key":"72716_CR15","doi-asserted-by":"crossref","unstructured":"E. Kibwana, M. Kapulu, P. Bejon, Controlled Human Malaria Infection Studies in Africa-Past, Present, and Future. Curr. Top Microbiol Immunol, (2022).","DOI":"10.1007\/82_2022_256"},{"key":"72716_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn5993","volume":"15","author":"DO Odera","year":"2023","unstructured":"Odera, D. O. et al. Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria. Sci. Transl. Med 15, eabn5993 (2023).","journal-title":"Sci. Transl. Med"},{"key":"72716_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2024.05.001","volume":"57","author":"IN Nkumama","year":"2024","unstructured":"Nkumama, I. N. et al. Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge. Immunity 57, 1215\u20131224.e1216 (2024).","journal-title":"Immunity"},{"key":"72716_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31640-6","volume":"13","author":"FK Musasia","year":"2022","unstructured":"Musasia, F. K. et al. Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria. Nat. Commun. 13, 4098 (2022).","journal-title":"Nat. Commun."},{"key":"72716_CR19","doi-asserted-by":"publisher","first-page":"e202301910","DOI":"10.26508\/lsa.202301910","volume":"7","author":"M Rosenkranz","year":"2024","unstructured":"Rosenkranz, M. et al. Full-length MSP1 is a major target of protective immunity after controlled human malaria infection. Life Sci. Alliance 7, e202301910 (2024).","journal-title":"Life Sci. Alliance"},{"key":"72716_CR20","doi-asserted-by":"publisher","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","volume":"6","author":"FH Osier","year":"2014","unstructured":"Osier, F. H. et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci. Transl. Med. 6, 247ra102 (2014).","journal-title":"Sci. Transl. Med"},{"key":"72716_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-108","volume":"10","author":"D Dodoo","year":"2011","unstructured":"Dodoo, D. et al. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar. J. 10, 108 (2011).","journal-title":"Malar. J."},{"key":"72716_CR22","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3389\/fimmu.2018.02866","volume":"9","author":"G Kamuyu","year":"2018","unstructured":"Kamuyu, G. et al. KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization. Front Immunol. 9, 2866 (2018).","journal-title":"Front Immunol."},{"key":"72716_CR23","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.csbj.2021.04.044","volume":"19","author":"K Mwai","year":"2021","unstructured":"Mwai, K. et al. protGear: A protein microarray data pre-processing suite. Computational Struct. Biotechnol. J. 19, 2518\u20132525 (2021).","journal-title":"Computational Struct. Biotechnol. J."},{"key":"72716_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07044-8","volume":"22","author":"MC Kapulu","year":"2022","unstructured":"Kapulu, M. C. et al. C.-S. S. Team, Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response. BMC Infect. Dis. 22, 86 (2022).","journal-title":"BMC Infect. Dis."},{"key":"72716_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"72716_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.medj.2023.07.003","volume":"4","author":"SE Silk","year":"2023","unstructured":"Silk, S. E. et al. Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults. Med. 4, 668\u2013686.e667 (2023).","journal-title":"Med"},{"key":"72716_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature13715","volume":"515","author":"KE Wright","year":"2014","unstructured":"Wright, K. E. et al. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature 515, 427\u2013430 (2014).","journal-title":"Nature"},{"key":"72716_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijpara.2008.10.006","volume":"39","author":"J Baum","year":"2009","unstructured":"Baum, J. et al. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J. Parasitol. 39, 371\u2013380 (2009).","journal-title":"Int J. Parasitol."},{"key":"72716_CR29","doi-asserted-by":"publisher","first-page":"eaap7847","DOI":"10.1126\/science.aap7847","volume":"360","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Science 360, eaap7847 (2018).","journal-title":"Science"},{"key":"72716_CR30","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1073\/pnas.1001323107","volume":"107","author":"PD Crompton","year":"2010","unstructured":"Crompton, P. D. et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. USA 107, 6958\u20136963 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72716_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00363-y","volume":"6","author":"AA Berry","year":"2021","unstructured":"Berry, A. A. et al. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome. NPJ Vaccines 6, 115 (2021).","journal-title":"NPJ Vaccines"},{"key":"72716_CR32","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1128\/IAI.01539-07","volume":"76","author":"T Tsuboi","year":"2008","unstructured":"Tsuboi, T. et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 76, 1702\u20131708 (2008).","journal-title":"Infect. Immun."},{"key":"72716_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep46086","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita, M. et al. Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate. Sci. Rep. 7, 46086 (2017).","journal-title":"Sci. Rep."},{"key":"72716_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.vaccine.2017.01.001","volume":"35","author":"BN Kanoi","year":"2017","unstructured":"Kanoi, B. N. et al. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda. Vaccine 35, 873\u2013881 (2017).","journal-title":"Vaccine"},{"key":"72716_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/infdis\/jiv224","volume":"212","author":"AE Dent","year":"2015","unstructured":"Dent, A. E. et al. Plasmodium falciparum protein microarray antibody profiles correlate with protection from symptomatic malaria in Kenya. J. Infect. Dis. 212, 1429\u20131438 (2015).","journal-title":"J. Infect. Dis."},{"key":"72716_CR36","doi-asserted-by":"publisher","first-page":"e1000218","DOI":"10.1371\/journal.pmed.1000218","volume":"7","author":"FJ Fowkes","year":"2010","unstructured":"Fowkes, F. J., Richards, J. S., Simpson, J. A. & Beeson, J. G. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med. 7, e1000218 (2010).","journal-title":"PLoS Med"},{"key":"72716_CR37","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1074\/mcp.M600035-MCP200","volume":"5","author":"PR Gilson","year":"2006","unstructured":"Gilson, P. R. et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteom. 5, 1286\u20131299 (2006).","journal-title":"Mol. Cell Proteom."},{"key":"72716_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2008.04.051","volume":"134","author":"AG Maier","year":"2008","unstructured":"Maier, A. G. et al. Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 134, 48\u201361 (2008).","journal-title":"Cell"},{"key":"72716_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1128\/MMBR.00014-16","volume":"80","author":"JD Warncke","year":"2016","unstructured":"Warncke, J. D., Vakonakis, I. & Beck, H. P. Plasmodium Helical Interspersed Subtelomeric (PHIST) Proteins, at the Center of Host Cell Remodeling. Microbiol Mol. Biol. Rev. 80, 905\u2013927 (2016).","journal-title":"Microbiol Mol. Biol. Rev."},{"key":"72716_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41586-018-0469-4","volume":"561","author":"CM Ho","year":"2018","unstructured":"Ho, C. M. et al. Malaria parasite translocon structure and mechanism of effector export. Nature 561, 70\u201375 (2018).","journal-title":"Nature"},{"key":"72716_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature13555","volume":"511","author":"B Elsworth","year":"2014","unstructured":"Elsworth, B. et al. PTEX is an essential nexus for protein export in malaria parasites. Nature 511, 587\u2013591 (2014).","journal-title":"Nature"},{"key":"72716_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403442121","volume":"121","author":"R McConville","year":"2024","unstructured":"McConville, R. et al. Flp\/FRT-mediated disruption of ptex150 and exp2 in Plasmodium falciparum sporozoites inhibits liver-stage development. Proc. Natl. Acad. Sci. USA 121, e2403442121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72716_CR43","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1074\/jbc.M111.328591","volume":"287","author":"HE Bullen","year":"2012","unstructured":"Bullen, H. E. et al. Biosynthesis, localization, and macromolecular arrangement of the Plasmodium falciparum translocon of exported proteins (PTEX). J. Biol. Chem. 287, 7871\u20137884 (2012).","journal-title":"J. Biol. Chem."},{"key":"72716_CR44","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1128\/IAI.00301-13","volume":"81","author":"KK Tetteh","year":"2013","unstructured":"Tetteh, K. K. et al. Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity. Infect. Immun. 81, 3835\u20133842 (2013).","journal-title":"Infect. Immun."},{"key":"72716_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/509806","volume":"195","author":"SD Polley","year":"2007","unstructured":"Polley, S. D. et al. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J. Infect. Dis. 195, 279\u2013287 (2007).","journal-title":"J. Infect. Dis."},{"key":"72716_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0166-6851(96)02826-5","volume":"85","author":"DR Cavanagh","year":"1997","unstructured":"Cavanagh, D. R. & McBride, J. S. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol. biochemical Parasitol. 85, 197\u2013211 (1997).","journal-title":"Mol. biochemical Parasitol."},{"key":"72716_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ab.2012.01.034","volume":"424","author":"Y Sun","year":"2012","unstructured":"Sun, Y., Gallagher-Jones, M., Barker, C. & Wright, G. J. A benchmarked protein microarray-based platform for the identification of novel low-affinity extracellular protein interactions. Anal. Biochem. 424, 45\u201353 (2012).","journal-title":"Anal. Biochem."},{"key":"72716_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B (Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol."},{"key":"72716_CR49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou, G. A modified poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159, 702\u2013706 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"72716_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani, R. THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL. Stat. Med. 16, 385\u2013395 (1997).","journal-title":"Stat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72716-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:46:55Z","timestamp":1786380415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72716"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72716-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All other authors declare no competing interests. In the CHMI-SIKA team, Y. A., P. F. B., S. L. H., E.R.J., B. K. L. S., and T. R. are salaried, full-time employees of Sanaria Inc., the manufacturer of Sanaria PfSPZ Challenge. Thus, all authors associated with Sanaria Inc. have potential conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6472"}}